VATELIZUMAB
UNII A4R7G50030

Substance Identification & Data

This profile provides standardized clinical and technical data for Vatelizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A4R7G50030.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1238217-55-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

A4R7G50030

CAS Registry Number

1238217-55-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VATELIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152838

National Cancer Institute reference terminology for clinical and research data.

INN ID

9439

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vatelizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VATELIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4, ANTI-(HUMAN .ALPHA.2.BETA.1 INTEGRIN I DOMAIN) (HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL LIGHT CHAIN, DIMER

VATELIZUMAB [INN]